http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004010135-A1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16322
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-645
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
filingDate 2002-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_993b054a5bf36c9484a492f18ffdcee0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e230d2d2fb9826f060da6482caf73be2
publicationDate 2004-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2004010135-A1
titleOfInvention Fusion protein delivery system and uses thereof
abstract The present invention provides a composition of matter, comprising: DNA encoding a viral Vpx protein fused to DNA encoding a protein. In another embodiment of the present invention, there is provided a composition of matter, comprising: DNA encoding a viral Vpr protein fused to DNA encoding a protein. The present invention further provides DNA, vectors and methods for expressing a lentiviral pol gene in trans, independent of the lentiviral gag-pol. A gene transduction element is optionally delivered to a lentiviral vector according to the present invention. Also provided are various methods of delivering a virus inhibitory molecule to a target in an animal. Further provided is a pharmaceutical composition.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7250498-B2
priorityDate 1995-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5378806-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5665577-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6043081-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5175099-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5981276-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6468539-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5861161-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5959
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409987
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406329
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10444661

Total number of triples: 33.